Matt

[Matt @mwl312]

@Bkov9 Which ticker we buying Ben? Boffem?

[Matt @mwl312]

@PsychedVantage @C_Angermayer @ApeironInvests @atai_life Well said. You guys provide some of, if not the best analysis and discussion in the space 🙏

[Matt @mwl312]

@PsychedVantage @C_Angermayer @ApeironInvests @atai_life Jake, greatly appreciate you sharing your thoughts , and I think you’re likely spot on. As a shareholder in both companies, torn between looking too deeply into this vs exiting $CMPS entirely at a loss and rolling into $ATAI or $GHRS If the ph 3 readout is strong, it may rip

[Matt @mwl312]

@C_Angermayer @ApeironInvests @atai_life I’ll take the like as a yes 😉 but this was always known, what changed? FDA feedback from Lykos fiasco?

[Matt @mwl312]

@C_Angermayer @ApeironInvests @atai_life Assume $CMPS not fitting the 2 hour window is why they are no longer a focus for $ATAI ?

[Matt @mwl312]

@lancefinlinson @V_arrell @AnthonyConigli0 EBITDA is relevant for m&a in a cash free debt free transaction, otherwise useless for a company’s ongoing operations as a metric of evaluation

[Matt @mwl312]

@RobertKennedyJr

[Matt @mwl312]

@RobertKennedyJr Lykos didn’t design the trial properly, FDA is corrupt but not at fault here in this case

[Matt @mwl312]

@V_arrell As expected at this point. 🙄

@todd_harrison tweeted something years ago regarding the next Depression and prohibition

[Matt @mwl312]

@Bkov9 Interesting you’re still tagging $SAM 🧐 😮

[Matt @mwl312]

@danobrien__ @V_arrell @PsychedVantage @Psy_Invest @Psyched_Alpha Sorry you are right, I used the incorrect terminology. Thank you

[Matt @mwl312]

$MNMD now worth more than $ATAI

How will commercialization even work without medical oversight? Great compound anecdotally IMO, but not seeing the end game personally

Thoughts? @V_arrell @PsychedVantage @Psy_Invest @Psyched_Alpha

[Matt @mwl312]

@V_arrell @PsychedVantage @Psy_Invest @Psyched_Alpha Thanks dude. Im always lurking on here, not too active tweet wise but gotta say @TheDalesReport is as good as it gets. Thank you for all you guys do

[Todd Harrison @todd_harrison]

$NVDA trading 155X the total market caps of all 🇺🇸 #cannabis public companies combined.

lets check this a year from now.

[Ian Cassel @iancassel]

I think about this Lou Brock quote a lot and how it relates to investing. The willingness to look wrong in the short-term to be right in the long-term.

"Show me a guy who's afraid to look bad, and I'll show you a guy you can beat every time."

[Matt @mwl312]

@WeedStreet420 Need volume though

[Matt @mwl312]

@PsychedInsights You guys mentioned Beckley in past videos I believe? What is your initial reaction to the news?

[Matt @mwl312]

@sammyj_19 I’m not the most sophisticated investor, but is this not insane for companies >$1B rev run rate to have these anemic trading volumes??

[Matt @mwl312]

@KieranO @BioLayne Surprised this is missing too